Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

149

Full text

109

Free full text

Publication Types

Journal Article

150

Research Support, Non-U.S. Gov't

Review

Randomized Controlled Trial

Clinical Trial

Research Support, N.I.H., Extramural

Comparative Study

Multicenter Study

Observational Study

Clinical Trial, Phase III

Systematic Review

Research Support, U.S. Gov't, Non-P.H.S.

Research Support, U.S. Gov't, P.H.S.

Controlled Clinical Trial

Meta-Analysis

Clinical Trial, Phase II

Letter

Case Reports

Consensus Development Conference

Clinical Trial, Phase I

Clinical Study

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2002

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""RANK Ligand""[mesh_terms]

152 Results

Searching titles within these results

Structure-based discovery and molecular dynamics evaluation of dihydrorobinetin as a potential anti-osteoclastogenic RANKL inhibitor in rheumatoid arthritis.

Devi Soorya Narayana S, Vino Sundararajan

Journal of biological physics 2025;51(1):29

Full Text

Abstract

An Overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions.

Desislava Daisy Ilchovska, Dr Michelle Barrow

Autoimmunity reviews 2021;20(2):102741

Full Text

Abstract

Probiotics and bone disorders: the role of RANKL/RANK/OPG pathway.

Virginia Boccardi, Negin Amin, Mohsen Taghizadeh, Sadegh Jafarnejad

Aging clinical and experimental research 2020;32(3):363-371

Full Text

Abstract

Osteoporosis and cardiovascular disease: an update.

A Capozzi, S Lello, G Scambia

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2016;31(8):590-4

Free Full Text

Abstract

OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational Study.

Jean Wactawski-Wende, Meryl S LeBoff, Jane A Cauley, Zhao Chen, Rebecca D Jackson, David Duggan, Andrea Z LaCroix, Aaron Aragaki, Charles Kooperberg

Bone 2014;56(2):474-81

Free Full Text

Abstract

OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration.

Herbert Marini, Letteria Minutoli, Francesca Polito, Alessandra Bitto, Domenica Altavilla, Marco Atteritano, Agostino Gaudio, Susanna Mazzaferro, Alessia Frisina, Nicola Frisina, Carla Lubrano, Michele Bonaiuto, Rosario D'Anna, Maria Letizia Cannata, Francesco Corrado, Francesco Cancellieri, Marianna Faraci, Rolando Marini, Elena Bianca Adamo, Steven Wilson, Francesco Squadrito

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(5):715-20

Free Full Text

Abstract

VDR, RANKL and OPG polymorphisms as possible predisposing cofactors of postmenopausal osteoporosis: explorative study in Italian population.

Gloria Bonaccorsi, Chiara Scapoli, Ilaria Crivellari, Leo Massari, Alberto Carrieri, Pantaleo Greco, Carlo Cervellati, Elisabetta Mamolini

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2018;33(12):937-941

Free Full Text

Abstract

Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids.

Rocío Ortiz-Muñiz, Lourdes Barbosa-Cortés, Salvador Atilano-Miguel

Boletin medico del Hospital Infantil de Mexico 2022;79(5):275-283

Free Full Text

Abstract

Molecular Mechanisms of Vascular Calcification in Chronic Kidney Disease: The Link between Bone and the Vasculature.

Chang Hyun Byon, Yabing Chen

Current osteoporosis reports 2016;13(4):206-15

Free Full Text

Abstract

Osteoclastogenesis and osteoimmunology.

Wei Feng, Wei Xia, Qing Ye, Weibing Wu

Frontiers in bioscience (Landmark edition) 2014;19(5):758-67

Free Full Text

Abstract

Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia.

Carlo Cervellati, Arianna Romani, Eleonora Cremonini, Carlo M Bergamini, Enrica Fila, Monica Squerzanti, Pantaleo Greco, Leo Massari, Gloria Bonaccorsi

Oxidative medicine and cellular longevity 2016;2016():6038798

Free Full Text

Abstract

Potential anti-catabolic and anabolic properties of strontium ranelate.

Saïd Kamel, Patrice Fardellone, Michel Brazier, Romuald Mentaverri

Current molecular pharmacology 2012;5(2):189-94

Full Text

Abstract

The effects of fatty acids consumption on OPG/RANKL/RANK system in cardiovascular diseases: Current status and future perspectives for the impact of diet-gene interaction.

Omid Reza Tamtaji, Shokoofeh Borzabadi, Majid Ghayour-Mobarhan, Gordon Ferns, Zatollah Asemi

Journal of cellular biochemistry 2020;120(3):2774-2781

Full Text

Abstract

Iguratimod, a synthetic disease modifying anti-rheumatic drug inhibiting the activation of NF-κB and production of RANKL: Its efficacy, radiographic changes, safety and predictors over two years' treatment for Japanese rheumatoid arthritis patients.

Junichiro Ishikawa, Koichiro Ishikawa

Modern rheumatology 2019;29(3):418-429

Full Text

Abstract

Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS).

Javier de Diego-Adeliño, Carlo Alemany Santamaria, Alejandra Inocencio Sánchez, Carlos Goicoechea García, Ángel Oteo-Álvaro

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2023;34(10):1799-1804

Full Text

Abstract

Results: 1 – 15 / 152

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""RANK Ligand""[mesh_terms]

Structure-based discovery and molecular dynamics evaluation of dihydrorobinetin as a potential anti-osteoclastogenic RANKL inhibitor in rheumatoid arthritis.

An Overview of the NF-kB mechanism of pathophysiology in rheumatoid arthritis, investigation of the NF-kB ligand RANKL and related nutritional interventions.

Probiotics and bone disorders: the role of RANKL/RANK/OPG pathway.

Osteoporosis and cardiovascular disease: an update.

OPG and sRANKL serum levels and incident hip fracture in postmenopausal Caucasian women in the Women's Health Initiative Observational Study.

OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration.

VDR, RANKL and OPG polymorphisms as possible predisposing cofactors of postmenopausal osteoporosis: explorative study in Italian population.

Duchenne muscular dystrophy: RANK/RANKL/OPG (receptor activator of nuclear factor-kB/RANK ligand/osteoprotegerin) system and glucocorticoids.

Molecular Mechanisms of Vascular Calcification in Chronic Kidney Disease: The Link between Bone and the Vasculature.

Osteoclastogenesis and osteoimmunology.

Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia.

Potential anti-catabolic and anabolic properties of strontium ranelate.

The effects of fatty acids consumption on OPG/RANKL/RANK system in cardiovascular diseases: Current status and future perspectives for the impact of diet-gene interaction.

Iguratimod, a synthetic disease modifying anti-rheumatic drug inhibiting the activation of NF-κB and production of RANKL: Its efficacy, radiographic changes, safety and predictors over two years' treatment for Japanese rheumatoid arthritis patients.

Neuropsychiatric adverse reactions in patients treated with denosumab: two case reports and a review of data from the FDA Adverse Event Reporting System (FAERS).

Results for
""RANK Ligand""[mesh_terms]